Dr Stephen Keith Funkhouser, DO | |
1202 Medical Center Drive, Attn: Credentialing, Wilmington, NC 28401-7307 | |
(910) 341-3300 | |
(910) 251-2067 |
Full Name | Dr Stephen Keith Funkhouser |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 14 Years |
Location | 1202 Medical Center Drive, Wilmington, North Carolina |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1154600633 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | 2016-01096 (North Carolina) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Memorial Mission Hospital And Asheville Surgery Ce | Asheville, NC | Hospital |
Blue Ridge Regional Hospital | Spruce pine, NC | Hospital |
Transylvania Regional Hospital, Inc | Brevard, NC | Hospital |
Highlands Cashiers Hospital | Highlands, NC | Hospital |
Angel Medical Center | Franklin, NC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Hospital Physician Services - Southeast Professional Corporation | 5597774554 | 640 |
News Archive
According to two experts in Britain the National Health Service (NHS) is needlessly spending at least 100m pounds per year on indigestion drugs.
Novartis announced today that the US Food and Drug Administration (FDA) has approved Zortress (everolimus) for the prophylaxis of organ rejection in adult patients receiving a liver transplant.
Aspirin is used by millions of patients for the prevention and treatment of coronary artery disease, the single leading cause of death in the world.
There is an uncommon risk of death that people with epilepsy and their loved ones may not know about. The risk is called sudden unexpected death in epilepsy, or SUDEP. Now the American Academy of Neurology and the American Epilepsy Society have co-developed a new guideline on SUDEP, published in the April 24, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology, and presented at the 69th AAN Annual Meeting in Boston, April 22 to 28, 2017.
Rush University Medical Center is leading a nationwide clinical trial of a nutritional drink to determine whether it can improve cognitive performance in people with mild to moderate Alzheimer's.
› Verified 2 days ago
Entity Name | J. Arthur Dosher Memorial Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1275660342 PECOS PAC ID: 8921910324 Enrollment ID: O20031104000362 |
News Archive
According to two experts in Britain the National Health Service (NHS) is needlessly spending at least 100m pounds per year on indigestion drugs.
Novartis announced today that the US Food and Drug Administration (FDA) has approved Zortress (everolimus) for the prophylaxis of organ rejection in adult patients receiving a liver transplant.
Aspirin is used by millions of patients for the prevention and treatment of coronary artery disease, the single leading cause of death in the world.
There is an uncommon risk of death that people with epilepsy and their loved ones may not know about. The risk is called sudden unexpected death in epilepsy, or SUDEP. Now the American Academy of Neurology and the American Epilepsy Society have co-developed a new guideline on SUDEP, published in the April 24, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology, and presented at the 69th AAN Annual Meeting in Boston, April 22 to 28, 2017.
Rush University Medical Center is leading a nationwide clinical trial of a nutritional drink to determine whether it can improve cognitive performance in people with mild to moderate Alzheimer's.
› Verified 2 days ago
Entity Name | Hospital Physician Services - Southeast Professional Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1760410385 PECOS PAC ID: 5597774554 Enrollment ID: O20100512000495 |
News Archive
According to two experts in Britain the National Health Service (NHS) is needlessly spending at least 100m pounds per year on indigestion drugs.
Novartis announced today that the US Food and Drug Administration (FDA) has approved Zortress (everolimus) for the prophylaxis of organ rejection in adult patients receiving a liver transplant.
Aspirin is used by millions of patients for the prevention and treatment of coronary artery disease, the single leading cause of death in the world.
There is an uncommon risk of death that people with epilepsy and their loved ones may not know about. The risk is called sudden unexpected death in epilepsy, or SUDEP. Now the American Academy of Neurology and the American Epilepsy Society have co-developed a new guideline on SUDEP, published in the April 24, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology, and presented at the 69th AAN Annual Meeting in Boston, April 22 to 28, 2017.
Rush University Medical Center is leading a nationwide clinical trial of a nutritional drink to determine whether it can improve cognitive performance in people with mild to moderate Alzheimer's.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Stephen Keith Funkhouser, DO 1202 Medical Center Drive, Attn: Credentialing, Wilmington, NC 28401-7307 Ph: (910) 341-3300 | Dr Stephen Keith Funkhouser, DO 1202 Medical Center Drive, Attn: Credentialing, Wilmington, NC 28401-7307 Ph: (910) 341-3300 |
News Archive
According to two experts in Britain the National Health Service (NHS) is needlessly spending at least 100m pounds per year on indigestion drugs.
Novartis announced today that the US Food and Drug Administration (FDA) has approved Zortress (everolimus) for the prophylaxis of organ rejection in adult patients receiving a liver transplant.
Aspirin is used by millions of patients for the prevention and treatment of coronary artery disease, the single leading cause of death in the world.
There is an uncommon risk of death that people with epilepsy and their loved ones may not know about. The risk is called sudden unexpected death in epilepsy, or SUDEP. Now the American Academy of Neurology and the American Epilepsy Society have co-developed a new guideline on SUDEP, published in the April 24, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology, and presented at the 69th AAN Annual Meeting in Boston, April 22 to 28, 2017.
Rush University Medical Center is leading a nationwide clinical trial of a nutritional drink to determine whether it can improve cognitive performance in people with mild to moderate Alzheimer's.
› Verified 2 days ago
Li Nichols, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2131 S 17th St, Wilmington, NC 28401 Phone: 910-667-7000 Fax: 910-815-5698 | |
James Adgent, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2131 S 17th St, Wilmington, NC 28401 Phone: 910-667-7000 Fax: 910-815-5698 | |
Benjamin Todd Freasier, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2131 S 17th St, Wilmington, NC 28401 Phone: 910-667-7000 Fax: 910-815-5698 | |
Dr. Oyakhire C Ofori, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1202 Medical Center Dr, Wilmington, NC 28401 Phone: 910-343-7000 Fax: 910-667-7908 | |
Udoaku Eberechuckwu Lintula, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2131 S 17th St, Wilmington, NC 28401 Phone: 910-815-5830 | |
Prasheen Piyush Shah, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1202 Medical Center Dr, Wilmington, NC 28401 Phone: 910-341-3300 Fax: 910-251-2067 |